AR and neoplasm: Analysis of tumor samples from patients with CRPC or xenograft models demonstrate that the reasons for androgen independence include overexpression of AR in many of these tumors, mutations in AR and its alternatively spliced forms [5], increased coactivator expression [6] and activation of AR by molecules such as cytokines or growth factors which cause stimulation of other cellular pathways that indirectly activate the AR [7, 8].